Table 2.

Summary of experimental parameters used to determine the frequency of CRU in primary recipients of SHIP+/+and SHIP−/−BM


Cell dose injected

Number positive

Number analyzed
SHIP+/+   
10 000   0   4  
50 000   0   3  
100 000   3   4  
250 000   2   3  
500 000   6   6  
1 000 000   8   8  
5 000 000   2   2  
10 000 000   5   5  
CRU frequency   1/148 102 (95% CI: 1/73 400-1/298 900)   
SHIP−/−   
3240   0   6  
50 000   0   3  
10 0000   0   4  
160 000   0   6  
500 000   1   5  
800 000   2   3  
1 000 000   2   5  
5 000 000   4   5  
CRU frequency
 
1/2 346 773 (95% CI: 1/1 135 500-1/4 850 070)*
 
 

Cell dose injected

Number positive

Number analyzed
SHIP+/+   
10 000   0   4  
50 000   0   3  
100 000   3   4  
250 000   2   3  
500 000   6   6  
1 000 000   8   8  
5 000 000   2   2  
10 000 000   5   5  
CRU frequency   1/148 102 (95% CI: 1/73 400-1/298 900)   
SHIP−/−   
3240   0   6  
50 000   0   3  
10 0000   0   4  
160 000   0   6  
500 000   1   5  
800 000   2   3  
1 000 000   2   5  
5 000 000   4   5  
CRU frequency
 
1/2 346 773 (95% CI: 1/1 135 500-1/4 850 070)*
 
 

To determine in vivo CRU regeneration levels, groups of recipients were killed 16 to 20 weeks after transplantation of 106 BM cells from SHIP+/+ or SHIP−/− mice, and the BM from these mice was evaluated by transplantation of the indicated cell doses into secondary Pep3b mice in a CRU assay. Mice reconstituted to 1% or more donor-type myeloid and 1% or more donor-type B-lymphoid cells were scored as positive.

*

P <.0001 versus wild type.

or Create an Account

Close Modal
Close Modal